Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
27 Décembre 2024 - 11:05PM
Edgar (US Regulatory)
Exhibit 1
JOINT FILING AGREEMENT
The undersigned acknowledge
and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments
to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing
agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and
accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information
is inaccurate.
Date: December 27, 2024
|
/s/ Mitchell P. Kopin |
|
Mitchell P. Kopin |
|
|
|
/s/ Daniel B. Asher |
|
Daniel B. Asher |
|
|
|
Intracoastal Capital LLC |
|
|
|
By: |
/s/ Mitchell P. Kopin |
|
|
Mitchell P. Kopin, Manager |
Phio Pharmaceuticals (NASDAQ:PHIO)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Phio Pharmaceuticals (NASDAQ:PHIO)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025